-
Tedalinab (GRC-10693) is a drug
developed by
Glenmark Pharmaceuticals for the
treatment of
osteoarthritis and
neuropathic pain,
which acts as a potent...
- O-1399 O-1602 O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447 VSN-16 WIN 55,212-2 WIN 56,098...
-
Olorinab (APD-371) PF-03550096 S-444,823 SER-601
Serinolamide A UR-144
Tedalinab THC (dronabinol) THCV
Tetrahydromagnolol Virodhamine Antagonists 4-O-Methylhonokiol...
- O-1399 O-1602 O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447 VSN-16 WIN 55,212-2 WIN 56,098...
-
Olorinab (APD-371) PF-03550096 S-444,823 SER-601
Serinolamide A UR-144
Tedalinab THC (dronabinol) THCV
Tetrahydromagnolol Virodhamine Antagonists 4-O-Methylhonokiol...
- O-1399 O-1602 O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447 VSN-16 WIN 55,212-2 WIN 56,098...
- O-1399 O-1602 O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447 VSN-16 WIN 55,212-2 WIN 56,098...
- O-1399 O-1602 O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447 VSN-16 WIN 55,212-2 WIN 56,098...
-
Olorinab (APD-371) PF-03550096 S-444,823 SER-601
Serinolamide A UR-144
Tedalinab THC (dronabinol) THCV
Tetrahydromagnolol Virodhamine Antagonists 4-O-Methylhonokiol...
-
Olorinab (APD-371) PF-03550096 S-444,823 SER-601
Serinolamide A UR-144
Tedalinab THC (dronabinol) THCV
Tetrahydromagnolol Virodhamine Antagonists 4-O-Methylhonokiol...
